Trademark Overview
On Friday, February 17, 2006, a trademark application was filed for MAVRIMAR with the United States Patent and Trademark Office. The USPTO has given the MAVRIMAR trademark a serial number of 78817960. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, July 3, 2007. This trademark is owned by Pfizer Inc.. The MAVRIMAR trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines, pain, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, allergies, diabetes,obesity, stroke, erectile and sexual dysfunction, and hemolytic diseases and disorders, pharmaceutical preparations, namely, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations; smoking cessation preparations, tissue and skin repair preparations and gynecological preparations; pharmaceutical preparations for the treatment of HIV/AIDS
